Today: 19 January 2026
Subscribe
Browse Category

Market News News 12 November 2025 - 14 November 2025

Binah Capital Group (BCG) Jumps on Q3 2025 Earnings Beat as AUM Hits $30 Billion

Binah Capital Group (BCG) Jumps on Q3 2025 Earnings Beat as AUM Hits $30 Billion

Binah Capital Group, Inc. (NASDAQ: BCG) is back in the spotlight today after releasing stronger‑than‑expected third‑quarter 2025 results and triggering a sharp move in its thinly traded stock. After the company reported double‑digit revenue growth, expanding margins, and a swing to GAAP profitability for the year to date, BCG shares spiked as much as ~75% in after‑hours trading on Thursday…
14 November 2025
···
Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd, Inc. (NASDAQ: IVVD) is back in the spotlight this Friday, November 14, 2025, with its stock exploding higher in pre‑market trading on the back of building momentum around its COVID‑19 antibody franchise and recent earnings. By early morning, IVVD was one of the most actively watched biotech names on Wall Street. Invivyd stock today: IVVD among top pre‑market gainers…
14 November 2025
··
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology (MU) Stock Today: What to Know Before the US Market Opens – November 14, 2025

Micron Technology stock is set for another volatile session on Friday, November 14, 2025, as Wall Street digests a powerful mix of Street‑high analyst upgrades, AI‑driven earnings momentum, stretched valuations, and a broad sell‑off in high‑growth tech and semiconductor names. Before the opening bell, here’s a complete rundown of what’s moving Micron Technology (NASDAQ: MU) today – and what traders…
14 November 2025
···
Gold Price Today, 14 November 2025: Spot Gold Holds Above $4,170 as Dollar Softens

Gold Price Today, 14 November 2025: Spot Gold Holds Above $4,170 as Dollar Softens

Gold is trading just below recent record highs on Friday, 14 November 2025, with spot prices holding comfortably above $4,170 per ounce as a weaker US dollar and lingering economic uncertainty keep demand for the metal strong. Reuters Below is a detailed, news-style breakdown of today’s gold price, the key drivers behind the move, and what’s happening in major physical…
14 November 2025
····
XRP Pops as DTCC Lists Five Spot ETFs—But Bearish Signals Linger: Whales Return, Volatility Rises (Nov. 10, 2025)

XRP Price Today (Nov 13, 2025): XRP Holds Near $2.33 as Nasdaq-Listed Spot XRP ETF (XRPC) Debuts

Published: November 13, 2025 XRP traded around $2.33 late Thursday, consolidating after an eventful session that saw the token swing between $2.28 and $2.52 while a new U.S. spot XRP exchange‑traded fund began trading on Nasdaq under the ticker XRPC. Market capitalization hovered near $140 billion, with 24‑hour volume above $7.5 billion. CoinMarketCap Key points Live XRP price (Nov 13,…
14 November 2025
····
Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power Inc. (TSX: NPI, NPI.TO) is under heavy pressure today after reporting third‑quarter 2025 results, cutting its dividend by 40% and warning that delays at its flagship Hai Long offshore wind project could hit 2026 revenues. The stock is trading around C$19 today, down more than 20% from Wednesday’s close near C$25, according to intraday quote data. StockInvest Key…
13 November 2025
····
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

US Stock Market Today – November 13, 2025: Futures Edge Higher as Shutdown Ends and Disney, Cisco Lead the Action

Wall Street heads into Thursday’s open with stock-index futures slightly green, a historic government shutdown finally over, and a packed earnings and data calendar that could shake up the recent rally. 1. Market snapshot before the opening bell US stock futures are pointing to a cautious positive start: These quotes are from early premarket trade, just after 4 a.m. New…
13 November 2025
····
Silver Near $50 – Is a New Record Imminent? Inside 2025’s Soaring Silver Surge

Silver Price Today, 13 November 2025: Spot XAG Hovers Near $54 as U.S. Shutdown Ends and Rate‑Cut Bets Lift Metals

Published: Thursday, 13 November 2025 Today’s snapshot What’s moving silver on 13 November 2025 1) Washington breakthrough fuels dovish expectations.U.S. President Donald Trump signed the bill to end the longest government shutdown, clearing the way for delayed data releases and strengthening expectations for a December Fed rate cut. That combination nudged precious metals higher, with silver tracking gold’s push to…
13 November 2025
····
Solvay Strikes Two U.S. Rare‑Earth Supply Deals as Europe Lags on Subsidies — Shares Rise on Nov. 13, 2025

Solvay Strikes Two U.S. Rare‑Earth Supply Deals as Europe Lags on Subsidies — Shares Rise on Nov. 13, 2025

Published: November 13, 2025 Belgium’s Solvay has signed two agreements to supply rare‑earth oxides to U.S. magnet makers Noveon Magnetics and Permag, a fresh sign that demand—and government backing—in North America is pulling new non‑Chinese supply into the market. The stock reacted on Thursday, rising about 3.4% to lead Belgium’s BEL 20 index. Reuters What happened Solvay said the Noveon…
13 November 2025
···
Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?

Gold Price Today, 13 November 2025: XAU/USD Holds Above $4,200 as U.S. Shutdown Ends and Rate‑Cut Bets Stay Alive

Gold is refusing to cool off. On Thursday, 13 November 2025, spot gold is holding comfortably above the $4,200 per ounce mark, extending a powerful rally that has already lifted prices about 60% higher this year. In early trade, different feeds show spot gold changing hands between roughly $4,210 and $4,240 an ounce, with Reuters quoting a morning high near…
13 November 2025
···
Palantir (PLTR) Today: Stock Slips as Valuation Debate Heats Up—Fresh Analyst Notes, $455B Market-Cap Talk, and What’s Next (12.11.2025)

Palantir (PLTR) Today: Stock Slips as Valuation Debate Heats Up—Fresh Analyst Notes, $455B Market-Cap Talk, and What’s Next (12.11.2025)

Palantir Technologies Inc. (NASDAQ: PLTR) traded lower this morning after a blistering multi‑month rally. New opinion pieces and analyst chatter out today are zeroing in on the same tension investors have wrestled with all year: explosive AI-driven growth vs. a sky‑high valuation. What’s new today (and why the stock is down) Stock check: Shares were recently trading lower intraday (see…
12 November 2025
····
Nasdaq Stumbles as Fed Jitters Mount, Intel Soars, Tariffs Rattle Tech Markets

US Stock Market Today, Nov. 12, 2025: Futures Climb as House Vote Aims to End Shutdown; CPI on Deck—What to Watch Before the Opening Bell

Date: Wednesday, November 12, 2025 Wall Street is leaning risk‑on in the pre‑market as investors eye a House vote that could end the record 42‑day federal shutdown and reopen key government data pipelines. Futures for the major indexes are higher, with the tone helped by resilient big‑cap earnings and fresh AI headlines. A packed macro slate—Fed speakers, energy reports and…
12 November 2025
····
1 … 55 56 57 58 59 … 64

Stock Market Today

  • Pfizer Q4 Preview: Non-Oncology Segment Sales Outlook and Market Impact
    January 19, 2026, 11:10 AM EST. Pfizer (PFE) is scheduled to report Q4 and full-year 2025 earnings on Feb. 3. While oncology sales account for over 28% of revenues, investor focus also shifts to non-oncology segments including Primary Care and Specialty Care. Key non-oncology products include Eliquis anticoagulant, Prevnar vaccines, COVID-19 vaccine Comirnaty, and newer drugs like RSV vaccine Abrysvo and migraine treatment Nurtec. Eliquis alliance revenues are expected to rise to $2.1 billion despite generic pressures. Prevnar vaccine sales likely declined in the U.S. but increased internationally, estimated at $1.64 billion. COVID-19 medication sales fell due to narrower vaccine recommendations and lower infections. In Specialty Care, Vyndaqel sales remain strong at an estimated $1.66 billion, while Xeljanz and Enbrel may have weakened. Pfizer's stock dropped 2.5% in past year, underperforming the industry, but trades at a forward price/earnings ratio of 8.58, suggesting valuation appeal.
Go toTop